AdvaMed Asks U.S. Court of Appeals to Support a Fair and Balanced Approach to Patent Damages
AdvaMed, the Medtech Association, asked the United States Court of Appeals to support a fair and balanced approach to patent damages.
AdvaMed Statement on President-elect Trump’s Intent to Nominate Dr. Martin Makary to Lead FDA
AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on President-elect Trump’s announcement that he intends to nominate Dr. Martin Makary to Lead FDA:
AdvaMed Releases White Paper Addressing Considerations of Third-Party Hardware Modification of Interventional X-Ray Equipment
AdvaMed, the Medtech Association, recently published a technical white paper outlining concerns with third-party modification of interventional X-ray equipment, which can pose unforeseen risks for patients and providers.
AdvaMed Welcomes Bipartisan Senate Bill to Expedite Medicare Coverage of Breakthrough Medical Technologies, Diagnostic Tests
AdvaMed, the Medtech Association, today welcomed introduction in the U.S. Senate of bipartisan legislation to expedite Medicare coverage of FDA-“breakthrough”-designated medical technologies and diagnostic tests. The legislation, the Ensuring Patient…
AdvaMed Statement on President-elect Trump’s Intent to Nominate Dr. Oz to Lead CMS
AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on President-elect Trump’s announcement that he intends to nominate Dr. Mehmet Oz to serve as Administrator…
AdvaMed Statement on Trump’s Intent to Nominate Kennedy as HHS Secretary
AdvaMed, the Medtech Association, today released the following statement from President and CEO Scott Whitaker on President-elect Trump’s intention to nominate Robert F. Kennedy, Jr., to serve as Secretary of…
AdvaMed Statement on Election 2024
AdvaMed, the Medtech Association, released the following statement on the 2024 election from President and CEO Scott Whitaker:
AdvaMed: Final CMS Payment Rules Contain Significant Victories for Patients
AdvaMed, the Medtech Association, today said two new final payment rules from the Centers for Medicare and Medicaid Services (CMS) for 2025 contain several important provisions that will improve access…
AdvaMed Calls on Medicare to Cover Supplemental Imaging as Part of Breast Cancer Screening
AdvaMed, the Medtech Association, called on Medicare in a letter sent Friday to cover supplemental imaging for women with heterogeneously and extremely dense breast tissue, noting the life-saving value of…
AdvaMed Welcomes Tarver as Head of CDRH
AdvaMed, the Medtech Association, which represents more than 500 medical technology companies of all sizes as the largest global trade organization for medtech, released the following statements on the FDA’s…